Cyient DLM stock fell 24% over two trading sessions as lower operating margins overshadowed a 26.5% jump in revenue. While the company reported strong demand in aerospace and industrial segments, increased spending on marketing and product development reduced profitability to 8.7%. Investors are now tracking the company's ability to balance its expansion strategy with margin recovery.
Cyient DLM witnessed a significant stock price correction, declining 24% over the last two trading sessions. On Monday, the stock fell another 13% to close at ₹783.55 on the BSE. This downward pressure reflects investor concern regarding the company's profitability metrics for the quarter ending September 2026.
While the company posted a solid 26.5% increase in revenue compared to the previous year, this growth was accompanied by a 130-basis-point contraction in EBITDA margins, which settled at 8.7%. Profit margins represent the money a company keeps from its revenue after paying for day-to-day operations. When these margins shrink, it often suggests that costs are rising faster than income. In this case, the company pointed to higher marketing expenses, costs associated with hiring a new Chief Growth Officer, and sustained investments in product development as the primary drivers of this margin decline.
Despite the immediate pressure on profitability, the company continues to focus on its three-stage strategic roadmap, which it calls 'Strengthen, Expand, and Transform.' This plan involves deepening its electronics manufacturing business while entering new high-growth areas like robotics and AI-powered data centers. Management indicated that the company currently holds a bid pipeline of more than $1 billion and is aiming to secure new orders in the range of $400 million to $500 million. The company reported that demand in its core aerospace and industrial segments remains strong.
Looking ahead, management remains optimistic about its financial performance, projecting revenue growth of over 30% for the second half of the fiscal year. They have set a target to improve EBITDA margins back toward the 11% level by fiscal year 2028, as they expect the benefits of their recent investments to start showing in the company's financial health. The company also noted that it is managing some minor delays in execution caused by longer supply chain lead times.
For investors, the primary monitorable will be how effectively the company can convert its large $1 billion bid pipeline into actual orders. Furthermore, the market will closely watch whether the company can successfully improve its profit margins as it scales up and begins to see the results of its current spending on expansion and marketing. Any improvement in execution or margin trajectory will be key to investor confidence in the coming quarters.